L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors
Status:
Completed
Trial end date:
2000-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of L-778,123 in treating patients with
recurrent or refractory solid tumors.